TTBK2
TTBK2 (tau tubulin kinase 2) is a serine/threonine kinase and a key regulator of ciliogenesis, acting at the basal body of the mother centriole. It is also known as KIAA0847 and SCA11, the latter from its previous name, spinocerebellar ataxia 11. Browse Assay Genie's current range of TTBK2 research reagents below, or read on for the biology behind the target.
TTBK2 controls the initiation of ciliogenesis. It binds to the distal end of the basal body and promotes removal of CCP110, which caps the mother centriole. Loss of this cap leads to recruitment of IFT proteins, which build the ciliary axoneme. TTBK2 also phosphorylates MPHOSPH9, promoting its ubiquitination and proteasomal degradation. Loss of MPHOSPH9 helps remove the CP110-CEP97 complex, a negative regulator of ciliogenesis, from the mother centrioles. TTBK2 is also required for recruitment of CPLANE2 and INTU to the mother centriole.
As an enzyme, TTBK2 shows some substrate preference for proteins already phosphorylated on a tyrosine residue at the +2 position relative to the phosphorylation site. It can phosphorylate tau on serines in vitro, and the NCBI Gene summary describes it as putatively phosphorylating tau and tubulin proteins, which gave the family its name. UniProt places it in the protein kinase superfamily, CK1 Ser/Thr protein kinase family, and HGNC classes it in the tau tubulin kinase family. Reported locations include the ciliary basal body, the centrosome and centriole, the cytosol and the nucleus.
Mutations in the TTBK2 gene cause spinocerebellar ataxia type 11 (SCA11), a neurodegenerative disease characterised by progressive ataxia and atrophy of the cerebellum and brainstem. This link explains the SCA11 alias and the previous gene name. The mouse ortholog is Ttbk2. Researchers studying TTBK2 typically work on centriole biology, cilium assembly and tau-related kinase signalling.
TTBK2 initiates cilium assembly by promoting CCP110 removal from the mother centriole and enabling IFT protein recruitment.
Mutations in the TTBK2 gene cause SCA11, a neurodegenerative disease with progressive ataxia and atrophy of the cerebellum and brainstem.
TTBK2 phosphorylates tau on serines in vitro, making it a kinase of interest for tau and tubulin regulation.
TTBK2 prefers substrates already phosphorylated on a tyrosine at the +2 position, offering a model for CK1-family substrate selection.
TTBK2 is a serine/threonine kinase that controls the initiation of ciliogenesis. It binds the distal end of the basal body and promotes removal of CCP110 from the mother centriole, which allows IFT proteins to be recruited and the ciliary axoneme to be built.
TTBK2 stands for tau tubulin kinase 2, and UniProt names it Tau-tubulin kinase 2. Aliases include KIAA0847 and SCA11. The gene was previously named spinocerebellar ataxia 11, reflecting the disease caused by its mutations.
Yes. Mutations in the TTBK2 gene cause spinocerebellar ataxia type 11, a neurodegenerative disease with progressive ataxia and atrophy of the cerebellum and brainstem. The mouse ortholog is Ttbk2; check the datasheet of any product for its validated reactivity.
Other tau tubulin kinases, centriole and ciliogenesis proteins, and tau-pathway targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q6IQ55; product specifications from Assay Genie datasheets.